Bailey & Company Advises DialysisPPO on its acquisition by ClaimsBridge

August 10, 2026 | News
DialysisPPO | ClaimsBridge Tombstone

NASHVILLE, TN (August 10, 2026): Bailey & Company announced today that it served as the exclusive financial advisor to DialysisPPO, a provider of a patented cost containment solution for End-Stage Renal Disease (ESRD) and chronic dialysis treatment that helps payers capture Medicare coordination savings, on its acquisition by ClaimsBridge, a leading provider of end-to-end claim and network technology solutions for TPAs, networks and employers. The acquisition of DialysisPPO follows a strategic investment in ClaimsBridge from Eir Partners Capital (Eir), a private equity firm focused on healthcare technology and tech-enabled services.

Together, the acquisition of DialysisPPO and the strategic investment from Eir, position ClaimsBridge to accelerate innovation for the self-funded and broader healthcare payer market while adding a specialized, patented solution for one of the fastest-growing and most expensive categories of medical spend. 

Eir’s investment builds on ClaimsBridge’s strong foundation, bringing capital and a proven track record of building healthcare technology platforms.  ClaimsBridge garners both savings and efficiencies, with their AI enhanced Celerity engine that offers a single vendor pre-adjudication claim workflow. Operationally, nothing changes for clients: the same team, processes, and standards of excellence in service remain in place. 

“Joining ClaimsBridge allows us to bring our ESRD savings program to a much broader base of payers, backed by ClaimsBridge’s technology, network reach, and client service model.  Just as important, our existing clients now gain access to a full suite of proven cost management solutions alongside the program they already rely on.” said John Brophy the CEO and Founder of DialysisPPO. 

“This is an important moment for ClaimsBridge,” said Kevin Gibson, CEO of ClaimsBridge. “Eir’s investment gives us the ability to accelerate innovation for our clients and the payer market, and DialysisPPO is the strongest solution we’ve seen for one of healthcare’s most complex and expensive conditions. Together, these moves reflect where we’re headed: simplifying complexity and taking cost out of the healthcare system.”

ABOUT DIALYSISPPO

DialysisPPO provides a patented cost containment solution for End-Stage Renal Disease (ESRD) and chronic dialysis treatment. The program helps payers capture Medicare coordination savings immediately for expansive savings. Learn more at dialysisppo.com.

ABOUT CLAIMSBRIDGE

ClaimsBridge is transforming the claims lifecycle with an end-to-end ecosystem of technology solutions, along with custom network and repricing services, that reduce costs, increase accuracy, and simplify complexity for payers. Learn more at claimsbridge.com. 

CONTACT INFORMATION

Patrick Keavy Headshot

Patrick Keavy

Managing Director

ABOUT BAILEY & COMPANY

Bailey & Company is a Nashville-based merchant banking platform focused on middle market healthcare companies in the healthcare services, healthcare technology, payer services and pharma services/medtech/life sciences sectors. As one of the largest independent, sector-focused investment banking and investing platforms in the country, Bailey & Company supports strong management teams that have built scalable platforms by providing strategic insights, world-class advice and access to one of the most diverse networks of industry experts. For more information see: www.bnco.com

We’re here to help you achieve your strategic objectives.

Let’s have a conversation about how we can put our deep expertise to work for you.

Send Us A Message